PHS
BIIB icon

PFM Health Sciences’s Biogen BIIB Stock Holding History

PFM Health Sciences’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-166,800
Closed -$44.5M – 90
2022
Q3 		$44.5M Hold
166,800
– – 1.61% 24
2022
Q2 		$34M Buy
+166,800
New +$34.1M 1.3% 33
2021
Q1 		– Sell
-160,000
Closed -$39.2M – 90
2020
Q4 		$39.2M Buy
+160,000
New +$41.3M 1.38% 29
2020
Q1 		– Sell
-30,300
Closed -$8.99M – 64
2019
Q4 		$8.99M Buy
+30,300
New +$8.41M 0.43% 52

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PFM Health Sciences's BIIB Position: Q4 2023 in Review

PFM Health Sciences sold out of Biogen (BIIB) in Q4 2023, closing a stake of 186,635 shares — an estimated $48M sold.

PFM Health Sciences first reported a position in BIIB in Q2 2013 and held it in 17 quarters. The position peaked at $185M in Q3 2016. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q4 2023.

  • PFM Health Sciences reported no remaining Biogen position as of Q4 2023 after selling out during the quarter.
  • PFM Health Sciences sold 186,635 Biogen shares in Q4 2023, an estimated $48M.
  • PFM Health Sciences first reported a position in Biogen in Q2 2013 and held it in 17 quarters.
  • PFM Health Sciences's Biogen position peaked at $185M in Q3 2016.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q4 2023.

Based on PFM Health Sciences's 13F filing for Q4 2023, filed 14 Feb 2024.